Back to User profile » Professor Mario Cazzola

Papers published by Professor Mario Cazzola:


Novel Anti-Inflammatory Approaches to COPD

Cazzola M, Hanania NA, Page CP, Matera MG

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1333-1352

Published Date: 29 June 2023

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset

Calverley PMA, Papi A, Page C, Rogliani P, Dal Negro RW, Cazzola M, Cicero AF, Wedzicha JA

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1909-1920

Published Date: 22 August 2022

Beyond Dual Bronchodilation – Triple Therapy, When and Why

Cazzola M, Rogliani P, Laitano R, Calzetta L, Matera MG

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:165-180

Published Date: 14 January 2022

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease

Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG

Biologics: Targets and Therapy 2021, 15:363-374

Published Date: 27 August 2021

New Avenues for Phosphodiesterase Inhibitors in Asthma

Matera MG, Ora J, Cavalli F, Rogliani P, Cazzola M

Journal of Experimental Pharmacology 2021, 13:291-302

Published Date: 15 March 2021

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

Ora J, Coppola A, Cazzola M, Calzetta L, Rogliani P

Journal of Experimental Pharmacology 2020, 12:559-574

Published Date: 8 December 2020

Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review

Rogliani P, Ritondo BL, Puxeddu E, Pane G, Cazzola M, Calzetta L

Journal of Experimental Pharmacology 2020, 12:233-253

Published Date: 6 August 2020

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

Calverley PMA, Page C, Dal Negro RW, Fontana G, Cazzola M, Cicero AF, Pozzi E, Wedzicha JA

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2733-2744

Published Date: 2 December 2019

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review

Rogliani P, Calzetta L, Braido F, Cazzola M, Clini E, Pelaia G, Rossi A, Scichilone N, Di Marco F

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3115-3130

Published Date: 4 October 2018

Doxofylline is not just another theophylline!

Matera MG, Page C, Cazzola M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3487-3493

Published Date: 5 December 2017

Acute exacerbations of COPD: risk factors for failure and relapse

Mantero M, Rogliani P, Di Pasquale M, Polverino E, Crisafulli E, Guerrero M, Gramegna A, Cazzola M, Blasi F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2687-2693

Published Date: 8 September 2017

Airflow obstruction: is it asthma or is it COPD?

Rogliani P, Ora J, Puxeddu E, Cazzola M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3007-3013

Published Date: 30 November 2016

COPD: the patient perspective

Jones PW, Watz H, Wouters EFM, Cazzola M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:13-20

Published Date: 19 February 2016

The clinical use of regenerative therapy in COPD

Lipsi R, Rogliani P, Calzetta L, Segreti A, Cazzola M

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1389-1396

Published Date: 12 December 2014

New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol

Cazzola M, Segreti A, Matera MG

Drug Design, Development and Therapy 2013, 7:1201-1208

Published Date: 10 October 2013